Compare PALI & DFDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | DFDV |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 219.8M |
| IPO Year | 2019 | N/A |
| Metric | PALI | DFDV |
|---|---|---|
| Price | $1.90 | $3.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $12.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 3.9M | 1.0M |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | $343.83 |
| Revenue Next Year | N/A | $104.68 |
| P/E Ratio | ★ N/A | $0.90 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $2.96 |
| 52 Week High | $2.64 | $53.88 |
| Indicator | PALI | DFDV |
|---|---|---|
| Relative Strength Index (RSI) | 50.99 | 42.84 |
| Support Level | $1.58 | $3.11 |
| Resistance Level | $2.05 | $5.14 |
| Average True Range (ATR) | 0.17 | 0.37 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 60.29 | 21.29 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.